ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in MYGN — Myriad Genetics Inc
CIK 1164508
BOSTON, MA
Position in MYGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$920,736
-$1,177,744 QoQ
Shares Held
204,608
+33.7% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,654,302,721 across 18 Diagnostics & Research names. MYGN ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
3,639,630 | $690,073,848 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
838,839 | $471,335,245 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
634,369 | $311,811,394 | |
| 4 | NTRA |
Natera, Inc.
|
1,191,732 | $238,334,482 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
395,769 | $190,044,316 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
134,906 | $170,143,447 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
992,190 | $169,208,082 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,439,782 | $164,106,352 |
All Filings in MYGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $920,736 | 204,608 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $2,098,480 | 153,062 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,863,943 | 177,581 | Shares | Defined | 2024-11-14 | |
| 2020-12-31 | $361,079 | 18,264 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,966,202 | 534,218 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,559,620 | 843,000 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||